09/21/2010

www.gupta-verlag.de/thermoplastic-elastomers

Purac to build new plant for biomedical resorbable polymers in the USA

The company currently operates a plant for biomedical polymers in the Netherlands. This second facility will be built in the USA. The investment for this new plant will be EUR 15 million. The construction of the facility will start in 2011 and is expected to be completed before the end of the year.

The Purac Biomaterials business comprises lactide based polymers such as poly lactic acid (PLA) and lactide/glycolide copolymers (PGLA).

www.gupta-verlag.de/thermoplastic-elastomers